InvestorsHub Logo

JellyDonut

11/10/16 8:06 PM

#5126 RE: Lazarus #5124

I don't see anywhere on their site that they have administered the drug before CTDH

To date, intravenous Trappsol® Cyclo™ has been administered to 21 NPC patients worldwide, some for more than five years, via multiple Compassionate Use Programs. During this time, multiple patients have shown marked improvements in neurological symptoms, lung function or liver morphology, or had stabilization of disease progression, with no significant, unexpected, safety concerns.